News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Merck to price bond amid CEO exit

Merck, the German pharmaceuticals company, has forged ahead with the sale of a €500m ($590m) bond despite the departure of its chief executive.

The company said on Tuesday evening that chief executive Bernard Scheuble had been replaced by board member Michael Roemer.

WSJ Logo